Literature DB >> 24709209

Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.

Ling Mei1, Ling Fu1, Kairong Shi1, Qianyu Zhang1, Yayuan Liu1, Jie Tang1, Huile Gao1, Zhirong Zhang1, Qin He2.   

Abstract

Though PEGylation has been widely used to enhance the accumulation of liposomes in tumor tissues through enhanced permeability and retention (EPR) effects, it still inhibits cellular uptake and affects intracellular trafficking of carriers. Active targeting molecules displayed better cell selectivity but were shadowed by the poor tumor penetration effect. Cell penetrating peptides could increase the uptake of the carriers but were limited by their non-specificity. Dual-ligand system may possess a synergistic effect and create a more ideal drug delivery effect. Based on the above factors, we designed a multistage liposome system co-modified with RGD, TAT and cleavable PEG, which combined the advantages of PEG, specific ligand and penetrating peptide. The cleavable PEG could increase the stability and circulation time of liposomes during circulation. After the passive extravasation to tumor tissues, the previously hidden dual ligands on the liposomes were exposed in a controlled manner at the tumor site through exogenous administration of a safe reducing agent L-cysteine. The RGD specifically recognized the integrins overexpressed on various malignant tumors and mediated efficient internalization in the synergistic effect of the RGD and TAT. Invitro cellular uptake and 3D tumor spheroids penetration studies demonstrated that the system could not only be selectively and efficiently taken up by cells overexpress ingintegrins but also penetrate the tumor cells to reach the depths of the avascular tumor spheroids. In vivo imaging and fluorescent images of tumor section further demonstrated that this system achieved profoundly improved distribution within tumor tissues, and the RGD and TAT ligands on C-R/T liposomes produced a strong synergistic effect that promoted the uptake of liposomes into cells after the systemic administration of L-cysteine. The results of this study demonstrated a tremendous potential of this multistage liposomes for efficient delivery to tumor tissue and selective internalization into tumor cells.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cleavable PEG; Multistage liposome; Synergistic effect; Tumor targeting

Mesh:

Substances:

Year:  2014        PMID: 24709209     DOI: 10.1016/j.ijpharm.2014.04.008

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  27 in total

Review 1.  Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer.

Authors:  Huan Meng; Andre E Nel
Journal:  Adv Drug Deliv Rev       Date:  2018-06-26       Impact factor: 15.470

Review 2.  Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.

Authors:  Sarah E Rowe; Jenna E Beam; Brian P Conlon
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

3.  Quantifying Carcinoembryonic Antigen-like Cell Adhesion Molecule-Targeted Liposome Delivery Using Imaging Flow Cytometry.

Authors:  Jason Kuhn; Asya Smirnov; Alison K Criss; Linda Columbus
Journal:  Mol Pharm       Date:  2019-05-13       Impact factor: 4.939

4.  In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.

Authors:  Ziqiang Ding; Dujin Wang; Wei Shi; Xiaomei Yang; Siliang Duan; Fengzhen Mo; Xiaoqiong Hou; Aiqun Liu; Xiaoling Lu
Journal:  Int J Nanomedicine       Date:  2020-10-29

Review 5.  Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances.

Authors:  Khaled Mahmoud; Shady Swidan; Mohamed El-Nabarawi; Mahmoud Teaima
Journal:  J Nanobiotechnology       Date:  2022-03-05       Impact factor: 10.435

Review 6.  Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.

Authors:  Jaleh Varshosaz; Maryam Farzan
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 7.  Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.

Authors:  Valery A Petrenko; James W Gillespie
Journal:  Expert Opin Drug Deliv       Date:  2016-08-05       Impact factor: 6.648

8.  Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.

Authors:  Zhongyuan Tang; Weiwei Feng; Yiqing Yang; Qun Wang
Journal:  Drug Des Devel Ther       Date:  2019-09-17       Impact factor: 4.162

9.  Simultaneous monitoring of the drug release and antitumor effect of a novel drug delivery system-MWCNTs/DOX/TC.

Authors:  Xia Dong; Zhiting Sun; Xiaoxiao Wang; Dunwan Zhu; Lanxia Liu; Xigang Leng
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide.

Authors:  Qianyu Zhang; Libao Lu; Li Zhang; Kairong Shi; Xingli Cun; Yuting Yang; Yayuan Liu; Huile Gao; Qin He
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.